Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2003
08/14/2003WO2003066078A1 Hiv inhibiting proteins
08/14/2003WO2003066077A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
08/14/2003WO2003066076A1 Method of protecting living body from foreign factor and composition therefor
08/14/2003WO2003066072A2 Cell therapy using immunoregulatory t-cells
08/14/2003WO2003066065A1 Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
08/14/2003WO2003066063A1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist
08/14/2003WO2003066050A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
08/14/2003WO2003066047A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
08/14/2003WO2003066037A1 Spermidine derivatives for the treatment of chronic neurodegenerative diseases
08/14/2003WO2003066033A1 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
08/14/2003WO2003066032A1 Formulations for inhalation
08/14/2003WO2003066026A1 Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier
08/14/2003WO2003066024A1 Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions
08/14/2003WO2003066003A2 Anti-pathogen treatements
08/14/2003WO2003065987A2 Granzyme b inhibitors
08/14/2003WO2003065985A2 Uses of mammalian cytokine; related reagents
08/14/2003WO2003065973A2 Multivalent streptococcal vaccine compositions and methods for use
08/14/2003WO2003065971A2 Non-myeloablative tolerogenic treatment with tyrphostins
08/14/2003WO2003065806A1 New immunoeffector compounds
08/14/2003WO2003045437A8 Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
08/14/2003WO2003045331A3 Formulations for oral administration of cromolyn sodium
08/14/2003WO2003043647A3 A plant extract active as an immunostimulating agent
08/14/2003WO2003037335A8 5-heteroatom-substituted pyrazoles
08/14/2003WO2003035237A3 Compounds for use as surfactants
08/14/2003WO2003032898A3 Modified human thymic stromal lymphopoietin
08/14/2003WO2003031568A8 Intracellular signaling molecules
08/14/2003WO2003030935A3 Adjuvants for nucleic acid vaccines
08/14/2003WO2003027232A3 Method for producing biologically active products
08/14/2003WO2003017935A3 Human antibodies specific for interleukin 15 (il-15)
08/14/2003WO2003002713A3 Antibodies to opgl
08/14/2003WO2003002069A3 Intradermal delivery of vaccines and gene therapeutic agents via microcannula
08/14/2003WO2002101048A3 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
08/14/2003WO2002099108A3 Atp-binding cassette transporter-like molecules and uses thereof
08/14/2003WO2002082085A3 Conditional autoimmune reaction by natural autoantibodies
08/14/2003WO2002081430A3 Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors
08/14/2003WO2002064083A3 Synthesis of 3-amino-thalidomide and its enantiomers
08/14/2003WO2002059154A9 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
08/14/2003WO2002057453A3 Polypetides and nucleic acids encoding same
08/14/2003WO2002051438A3 Use of repulsive guidance molecule (rgm) and its modulators
08/14/2003WO2002029055A3 Carbohydrate-associated proteins
08/14/2003WO2002013866A9 Stimulating neutrophil function to treat inflammatory bowel disease
08/14/2003WO2001092527A3 Regulators of apoptosis
08/14/2003US20030153750 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
08/14/2003US20030153621 Administering mixtures of 13-hydroxyoctadeca-9Z,11E-dienoic acid (13-HODE) and carriers comprising glycerides or fatty esters as controllers of endothelial growth factors
08/14/2003US20030153615 Novel compositions and uses of dictyostatin compounds
08/14/2003US20030153587 Such as 3-((3-bromo-4-hydroxyphenyl)methyl)-5-ethyl-7,8-dihydro-2-(tetrahydro-2H -pyran-4-yl)amino)-3H-imidazo(2,1-b) purin-4(5H)-one for treating sexual disorders
08/14/2003US20030153575 Tetracyclic diketopiperazine compounds as pdev inhibitors
08/14/2003US20030153569 Novel pyrazole and pyrazoline substituted compounds
08/14/2003US20030153568 Serine/threonine and tyrosine kinases inhibitors
08/14/2003US20030153566 Adenosine receptor agonist
08/14/2003US20030153563 CRF receptor antagonists and methods relating thereto
08/14/2003US20030153559 Treatment of an oxygen and/or energy deficit; a poly(adenosine diphosphate ribose)-polymerase inhibitor; treating autoimmune, neurodegenerative and diseases caused by a toxic effect; viricides
08/14/2003US20030153558 Immunomodulators and/or inhibiting cytokine release
08/14/2003US20030153542 Novel anti-inflammatory androstane derivative compositions
08/14/2003US20030153540 For improving health in a woman having elevated sex hormone binding globulin levels, or who is receiving oral estrogen supplementation
08/14/2003US20030153536 Compounds and methods of treating transplant rejection
08/14/2003US20030153523 Screening library of test compounds, each of which is attached to a solid support, with a dye-labeled RNA molecule to form a dye-labeled target RNA:support-attached test compound complex
08/14/2003US20030153518 Activation and inhibition of the immune system
08/14/2003US20030153507 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
08/14/2003US20030153082 An isolated population of human hematopoietic cells that proliferates in culture, obtained by differentiating primate pluripotent stem (pPS) cells, and atleast 1% cells are CD45 + and population forms colonies
08/14/2003US20030153073 Expansion of T cells in vitro and expanded T cell populations
08/14/2003US20030152956 Modulating gene expression of carboxypeptidase M, cathepsin C, endothelin-A receptor, and/or osteoblast specific factor by stimulating respiratory tract epithelial cells with interleukins; drug screening
08/14/2003US20030152947 Methods for detecting and treating the early onset of aging-related conditions
08/14/2003US20030152653 Echinacea supplement and method of manufacture
08/14/2003US20030152651 Herbal composition for angina pectoris, method to prepare same and uses thereof
08/14/2003US20030152626 Substance P antagonist; antidepressants; central nervous system disorders; respiratory system disorders
08/14/2003US20030152595 Storage stability
08/14/2003US20030152594 Immunology response intensifiers; administering a bacterial lysate
08/14/2003US20030152589 Infecting with bacteriophage; inducting immunology response; forming antibodies
08/14/2003US20030152587 Immunomoderators; high molecular weight polysaccharides
08/14/2003US20030152550 Dendritic cells and the uses thereof in screening cellular targets and potential drugs
08/14/2003US20030151560 Antenna system for a level measurement apparatus
08/14/2003CA2485064A1 Albumin-fused kunitz domain peptides
08/14/2003CA2483630A1 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations
08/14/2003CA2475767A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
08/14/2003CA2475637A1 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003CA2475539A1 Hiv inhibiting proteins
08/14/2003CA2475382A1 Albumin-fused anti-angiogenesis peptides
08/14/2003CA2475329A1 Truncated aggrecanase molecules
08/14/2003CA2475247A1 Anti-pathogen treatments
08/14/2003CA2475101A1 Recombinant bovine immunodeficiency virus based gene transfer system
08/14/2003CA2474974A1 Cytoprotective benzofuran derivatives
08/14/2003CA2474917A1 Granzyme b inhibitors
08/14/2003CA2474800A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
08/14/2003CA2474748A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003CA2474709A1 Immunostimulatory, covalently lipidated oligonucleotides
08/14/2003CA2474398A1 New immunoeffector compounds
08/14/2003CA2474214A1 Novel aryl- and heteroarylpiperazines
08/14/2003CA2474186A1 Compositions and methods for restoring immune responsiveness in patients with immunological defects
08/14/2003CA2474011A1 Use of the mammalian cytokine, tslp/il-50, for modulating dendritic cell activity and treatment of immune disorders
08/14/2003CA2473182A1 Compositions and methods for treatment of vitamin d deficiency
08/14/2003CA2467555A1 Preparation of pharmaceutical salts of 4 ( (z) - (4-bromophenyl) (ethoxyimino) methyl)-1'-( (2,4-dimethyl-1-oxido-3-pyridinyl) carbonyl) -4'-me thyl-1,4' bipiperidine as ccr5-antagonists for the treatment of aids and related hiv infections
08/14/2003CA2466251A1 Therapeutic use of aziridino compounds
08/14/2003CA2464527A1 Multivalent streptococcal vaccine compositions and methods for use
08/14/2003CA2450807A1 Non-myeloablative tolerogenic treatment with tyrphostins
08/13/2003EP1335023A2 Methods and reagents for vaccination which generate a CD8 T cell immune response
08/13/2003EP1334984A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
08/13/2003EP1334982A2 Solubilized complement receptor type 1 in crystal form
08/13/2003EP1334729A1 Therapeutic use of non-neurotoxic clostridium botulinum toxin type C2
08/13/2003EP1334718A1 Drug composition comprising dipeptydyl aldehyde derivative
1 ... 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 ... 1172